| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.513 | 1.706 | 4.112 | 5.937 | 4.050 | 8.671 | 8.483 |
| Total Income - EUR | - | - | - | 3.513 | 1.706 | 4.112 | 5.937 | 4.050 | 8.671 | 8.483 |
| Total Expenses - EUR | - | - | - | 769 | 1.208 | 2.003 | 2.758 | 3.993 | 5.075 | 5.550 |
| Gross Profit/Loss - EUR | - | - | - | 2.745 | 498 | 2.109 | 3.179 | 57 | 3.596 | 2.933 |
| Net Profit/Loss - EUR | - | - | - | 2.639 | 447 | 1.989 | 2.996 | -64 | 2.934 | 2.492 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cabinet Neurologie Dr. Vîrdol Maria-Alina S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 1.008 | 1.123 | 779 | 429 | 444 | 441 |
| Current Assets | - | - | - | 2.750 | 2.069 | 3.912 | 7.132 | 5.409 | 7.247 | 10.218 |
| Inventories | - | - | - | 0 | 440 | 0 | 0 | 130 | 0 | 0 |
| Receivables | - | - | - | 537 | 51 | 0 | 0 | 22 | 14 | 547 |
| Cash | - | - | - | 2.212 | 1.578 | 3.912 | 7.132 | 5.256 | 7.233 | 9.671 |
| Shareholders Funds | - | - | - | 2.682 | 3.077 | 5.008 | 7.893 | 5.825 | 7.593 | 10.043 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 67 | 0 | 28 | 18 | 12 | 97 | 616 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Neurologie Dr. Vîrdol Maria-Alina S.r.l.